Deka Bank Deutsche Girozentrale Supernus Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 22,200 shares of SUPN stock, worth $855,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,200

Previous 22,200 -0.0%

Holding current value

$855,809

Previous $595,000 13.28%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$27.11 - $35.17 $259,578 - $336,752	-9,575 Reduced 30.13%	22,200 $743,000
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $263,982 - $315,113	9,575 Added 43.13%	31,775 $888,000
Q1 2022 Apr 28, 2022	BUY	$28.51 - $32.9 $57,020 - $65,800	2,000 Added 9.9%	22,200 $719,000
Q4 2021 Feb 02, 2022	BUY	$26.37 - $34.22 $13,185 - $17,110	500 Added 2.54%	20,200 $605,000
Q3 2020 Oct 29, 2020	BUY	$20.2 - $25.05 $397,940 - $493,485	19,700 New	19,700 $402,000
Q4 2019 Feb 04, 2020	SELL	$19.93 - $29.13 $809,158 - $1.18 Million	-40,600 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.47 - $33.37 $285,264 - $373,744	-11,200 Reduced 21.62%	40,600 $1.12 Million
Q2 2019 Aug 01, 2019	BUY	$29.96 - $38.87 $602,196 - $781,287	20,100 Added 63.41%	51,800 $1.66 Million
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $190,066 - $243,542	5,800 Added 22.39%	31,700 $1.38 Million
Q4 2018 Feb 12, 2019	SELL	$30.84 - $49.51 $178,872 - $287,158	-5,800 Reduced 18.3%	25,900 $844,000
Q3 2018 Nov 09, 2018	SELL	$42.7 - $56.55 $34,160 - $45,240	-800 Reduced 2.46%	31,700 $0
Q2 2018 Aug 14, 2018	BUY	$44.1 - $59.85 $529,200 - $718,200	12,000 Added 58.54%	32,500 $1.9 Million
Q1 2018 May 03, 2018	SELL	$37.15 - $46.9 $200,610 - $253,260	-5,400 Reduced 20.85%	20,500 $939,000
Q3 2017 Nov 06, 2017	BUY	$36.75 - $49.65 $951,825 - $1.29 Million	25,900	25,900 $1.18 Million

Others Institutions Holding SUPN

# of Institutions

283

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.06B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Supernus Pharmaceuticals, Inc. Transaction History